Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) is now available.
Dawnrays Pharmaceutical Holdings Ltd. announced that all proposed ordinary resolutions were passed at their Annual General Meeting held on May 23, 2025. Key resolutions included the approval of financial statements, declaration of dividends, re-election of directors, and granting of mandates to issue and repurchase shares. This outcome reflects strong shareholder support and positions the company for continued strategic actions in the market.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. is a company incorporated in the Cayman Islands, primarily operating in the pharmaceutical industry. The company focuses on the development, manufacture, and sale of pharmaceutical products, with a market presence in Hong Kong.
Average Trading Volume: 249,758
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.79B
Find detailed analytics on 2348 stock on TipRanks’ Stock Analysis page.